Search the Video Library

Filter by Date

Video Language

Filter by Cancer Type:

Displaying Results 31 - 32 of 32

Local Therapy for Limited Acquired Resistance

Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, describes the types of situations in which local therapy is appropriate for treating limited acquired resistance.

ALK Inhibitors for Acquired Resistance: Zykadia and Alectinib

Dr. Nathan Pennell, Cleveland Clinic, discusses acquired resistance to Xalkori in ALK-positive patients, and second generation inhibitors designed to overcome that resistance, such as Zykadia and alectinib.